Skip to main content
SpringerLink
Log in

Evaluation of Patients with Known Coronary Artery Disease

  • Chapter
  • First Online:
Handbook of Nuclear Cardiology

  • 2582 Accesses

Abstract

Patients with coronary artery disease are at increased risk for cardiac events. According to the American Heart Association heart disease and stroke statistics [1], the estimated annual incidence of myocardial infarction (MI) in the United States is 610,000 new attacks and 325,000 recurrent attacks, and 16,300,000 Americans ≥20 years of age have coronary artery disease (CAD). Despite the high prevalence, prognosis for patients with known CAD has improved significantly during the last decades, with the identification and aggressive management of risk factors as well as the wide use of revascularization procedures and anti-platelet agents. As a result, in everyday practice physicians are called upon to evaluate and follow-up a substantial number of patients with known CAD, many of whom have undergone one or more revascularization procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–e209.

    Article  PubMed  Google Scholar 

  2. Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53(23):2201–29.

    Article  PubMed  Google Scholar 

  3. Hendel RC, Abbott BC, Bateman TM, et al. The role of radionuclide myocardial perfusion imaging for asymptomatic individuals. J Nucl Cardiol. 2011;18(1):3–15.

    Article  PubMed  Google Scholar 

  4. Giedd KN, et al. Myocardial perfusion imaging following percutaneous coronary intervention. The importance of restenosis, disease progression, and directed reintervention. J Am Coll Cardiol. 2004;13:328–36.

    Article  Google Scholar 

  5. Holmes Jr DR, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coll Cardiol. 2010;56(17):1357–65.

    Article  PubMed  Google Scholar 

  6. Lee TH, Boucher CA. Non-invasive tests in patients with stable coronary artery disease. N Engl J Med. 2001;345(18):1351.

    Google Scholar 

  7. Gibbons RJ, Balady GJ, Bricker LT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol. 2002;40(8):1531–40.

    Article  PubMed  Google Scholar 

  8. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden. Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283–91.

    Article  PubMed  Google Scholar 

  9. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010;31(20):2501–55.

    Article  PubMed  Google Scholar 

  10. Shehata AR, Gillam LD, Mascitelli VA, et al. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol. 1997;80(3):268–72.

    Article  PubMed  CAS  Google Scholar 

  11. Mahmarian JJ, Fenimore NL, Marks GF, et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, ­placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol. 1994;24(1):25–32.

    Article  PubMed  CAS  Google Scholar 

  12. Schwartz RG, Pearson TA, Kalaria VG, et al. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol. 2003;42(4):600–10.

    Article  PubMed  CAS  Google Scholar 

  13. Cottin Y, Rezaizadeh K, Touzery C, et al. Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting. Am Heart J. 2001;141(6):999–1006.

    Article  PubMed  CAS  Google Scholar 

  14. Zellweger MJ, Weinbacher M, Zutter AW, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol. 2003;42(1):33–40.

    Article  PubMed  Google Scholar 

  15. Palmas W, Bingham S, Diamond GA, et al. Incremental prognostic value of exercise thallium-201 myocardial SPECT late after coronary artery bypass surgery. J Am Coll Cardiol. 1995;25:403–9.

    Article  PubMed  CAS  Google Scholar 

  16. Zellweger MJ, Lewin HC, Lai S, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol. 2001;37(1):144–52.

    Article  PubMed  CAS  Google Scholar 

  17. Lauer MS, Lytle B, Pashkow F, et al. Prediction of death and myocardial infarction by screening with exercise-thallium testing after coronary-artery-bypass grafting. Lancet. 1998;351(9103):615–22.

    Article  PubMed  CAS  Google Scholar 

  18. Mahmarian JJ, Shaw LJ, Filipchuk NG, for the INSPIRE investigators, et al. A multinational study to establish the value of early adenosine technetium-99 m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol. 2006;48(12):2448–57.

    Article  PubMed  Google Scholar 

  19. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA guidelines for NSTEMI/UA 2007…ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1–e157.

    Article  PubMed  Google Scholar 

  20. Canon CP, Weintraub WS, Demopoulos LA, et al. TACTICS-Thrombolysis in Myocardial Infarction (TIMI) -18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. N Engl J Med. 2001;344:1879.

    Article  Google Scholar 

  21. Antman EM, Cohen M, Bernink PJ, et al. The TIMI score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–42.

    Article  PubMed  CAS  Google Scholar 

  22. Heller GV, Hendel RC. Evaluation of ischemia therapies in patients with coronary artery disease. In: Malik A, Heller GV, editors. Nuclear cardiology: practical applications. 2nd ed. New York: McGraw-Hill Medical; 2010.

    Google Scholar 

  23. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment. J Am Coll Cardiol. 1991;17(5):1053–7.

    Article  PubMed  CAS  Google Scholar 

  24. Stratman HG, Younis LT, Wittry MD, et al. Exercise technetium-99 m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol. 1995;76(4):236–40.

    Article  Google Scholar 

  25. Cerqueira MD, Allman KC, Ficaro EP, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol. 2010;17(4):709–18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Christiana Care Health Systems, Newark, 19702, DE, USA

    Dimitrios Barmpouletos M.D.

  2. University of Connecticut School of Medicine, Farmington, CT, USA

    Gary V. Heller M.D., Ph.D., FACC (Professor of Medicine)

  3. Intersocietal Accreditation Commission, 6021 University Blvd, Ellicott City, MD, 21043, USA

    Gary V. Heller M.D., Ph.D., FACC (IAC Research Officer)

Authors
  1. Dimitrios Barmpouletos M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary V. Heller M.D., Ph.D., FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gary V. Heller M.D., Ph.D., FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gary V. Heller M.D., Ph.D., FACC .

Editor information

Editors and Affiliations

  1. Hartford Hospital, Seymour Street 80, Hartford, 06106, Connecticut, USA

    Gary V. Heller

  2. , Miller School of Medicine, University of Miami, Miami, 33136, Florida, USA

    Robert C. Hendel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Barmpouletos, D., Heller, G.V., Heller, G.V. (2013). Evaluation of Patients with Known Coronary Artery Disease. In: Heller, G., Hendel, R. (eds) Handbook of Nuclear Cardiology. Springer, London. https://doi.org/10.1007/978-1-4471-2945-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2945-5_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2944-8

  • Online ISBN: 978-1-4471-2945-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation